CME Credit for Physicians
ACCME Accreditation Statement
The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The American Association for the Study of Liver Diseases designates this other (live and online) activity for a maximum of 176.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
ABIM Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for the Study of Liver Diseases. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
CME Session Credits
Please click on the link to see the list of CE credits awarded for each of the different sessions offered at TLM 2025.
Credit Claiming Period
Credit Claiming for The Liver Meeting 2025 will open on November 7. The following is the process to be completed once appropriate.
Medium and Method of Physician Participation:
- Register for The Liver Meeting®
- Attend The Liver Meeting® in Washington, DC and/or view live streamed sessions online between November 7-November 11, 2025.
- View recordings of sessions presented in person at The Liver Meeting® online between November 12 and December 31, 2025 if desired.
- Complete the meeting evaluation and identify all completed sessions on the transcript. The meeting evaluation is available at https://www.compusystems.com/jsp/CEU/AASLD25/ceu.jsp
- Print and/or download a CME certificate if desired.
Other Healthcare Providers
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 26.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 26.75 ANCC contact hours.
Other Professions
Nurse Pharmacology Credits
Please note sessions listed below eligible for pharmacotherapeutic hours andself-submit those to your board. Keep the agenda as a reference in case theyhave questions. Maximum of 18.50 hours.
- Hepatology Associates Course, Part 1:Hepatology Associates as Leaders in Multidisciplinary Care (1.50 Hours)
- Hepatology Associates Course, Part 2:Novel Insights From Hepatology Associates (1.50 Hours)
- Postgraduate Course, Parts 1-4: A Lifetime of Liver Health (8.00 Hours)
- Applications of Real-World Data in Clinical Practice (1.50 Hours)
- Hepatotoxicity and Pediatric Liver Disorders Special Interest Groups Joint Symposium, Part 1. Drug-Induced Liver Injury: Drug-Induced Liver Injury Across the Lifespan Advances in Management (1.50 Hours)
- Hepatotoxicity and Pediatric Liver Disorders Special Interest Groups Joint Symposium, Part 2. Drug-Induced Liver Injury: Emerging Trends in Drug-Induced Liver Injury From Children to Adults (.75 Hours)
- Managing the ABCs of Liver Disease (1.50 Hours)
- MTE #10 Drug-Induced Liver Injury from Herbal and Dietary Supplements in2025: New Kids on the Block (1.50 Hours)
- MTE #17 Refractory Immune-Mediated Liver Injury from Checkpoint Inhibitors:When to Bring Out the Big Guns? (.75 Hours)
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
How to Get Your Certificate
- Go to aasld.cmecertificateonline.com
- Click on the 2025 The Liver Meeting link
- Evaluate the meeting.
- Print, download, or save your certificate for your records.
- If you lose your certificate, or need help, go to help.cmecertificateonline.com
Other Advanced Providers
The AAPA, ANCC and AANP accept reports from advanced practitioners of their participation in activities offering AMA PRA Category 1 CreditsTM for continuing education and credentialing purposes. For more information, please contact the appropriate organization.
Questions
Questions related to credit claiming should be directed to Education@aasld.org
Commercial Support
Updates on commercial support opportunities for The Liver Meeting® 2025 will be posted here as they become available.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the latest basic, translational, and clinical research in hepatology with researchers and their peers
- Apply current guidelines and research to their practices, whether clinical care, education, or teaching
- Engage in peer-to-peer learning to reinforce lessons learned from meeting faculty
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed HERE.